THE TREATMENT OF DISSEMINATED PROSTATE-CANCER WITH ESTRAMUSTINE

被引：1
|
作者：
ROSENTHAL, MA [1 ]
RAGHAVAN, D [1 ]
STUARTHARRIS, R [1 ]
ACKLAND, S [1 ]
GRYGIEL, J [1 ]
机构：
[1] ROYAL PRINCE ALFRED HOSP,UROL CANC RES UNIT,LEVEL E9,CAMPERDOWN,NSW 2050,AUSTRALIA
来源：
AUSTRALIAN AND NEW ZEALAND JOURNAL OF SURGERY | 1992年 / 62卷 / 11期
关键词：
ESTRAMUSTINE; PROSTATE CANCER;
D O I：
10.1111/j.1445-2197.1992.tb06942.x
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
Forty-three patients with disseminated prostate cancer, resistant to orchidectomy or hormone therapy with estramustine were treated. Of the 33 evaluable patients, three patients had stable disease and two had a partial tumour response according to National Prostatic Cancer Project criteria. Twenty-five patients (58%) showed improvement in pain and urinary symptoms. Ten patients (23%) had side effects requiring cessation of therapy. These results show that estramustine has a limited role in the treatment of advanced prostate cancer and that therapy is frequently associated with intolerable side effects.
引用
收藏
页码：871 / 873
页数：3
相关论文
共 50 条
  • [1] ESTRAMUSTINE FOR PROSTATE-CANCER
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 1982, 24 (615): : 74 - 74
  • [2] INHIBITION OF PROSTATE-CANCER GROWTH BY ESTRAMUSTINE AND COLCHICINE
    FAKIH, M
    YAGODA, A
    REPLOGLE, T
    LEHR, JE
    PIENTA, KJ
    PROSTATE, 1995, 26 (06): : 310 - 315
  • [3] INHIBITION OF PROSTATE-CANCER GROWTH BY ESTRAMUSTINE AND ETOPOSIDE
    PIENTA, KJ
    REDMAN, BG
    HUSSAIN, M
    ESPER, PS
    FLAHERTY, LE
    CANCER, 1995, 75 (07) : 1920 - 1926
  • [4] ANALYSIS OF RESPONSE OF METASTATIC PROSTATE-CANCER TO ESTRAMUSTINE THERAPY
    CITRIN, DL
    COHEN, AI
    HARBERG, J
    SCHLISE, S
    HOUGEN, C
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 425 - 425
  • [5] EXPERIENCES WITH ESTRAMUSTINE PHOSPHATE (ESTRACYT, EMCYT) IN PROSTATE-CANCER
    MURPHY, GP
    SLACK, NH
    MITTELMAN, A
    SEMINARS IN ONCOLOGY, 1983, 10 (03) : 34 - 42
  • [6] ESTRAMUSTINE PHOSPHATE AND OTHER CYTOTOXIC DRUGS IN THE TREATMENT OF POOR PROGNOSTIC ADVANCED PROSTATE-CANCER
    JANKNEGT, RA
    PROSTATE, 1992, : 105 - 110
  • [7] TREATMENT OF PROSTATE-CANCER
    KORMAN, LB
    CLINICAL PHARMACY, 1989, 8 (06): : 412 - 424
  • [8] PACLITAXEL PLUS ESTRAMUSTINE IN METASTATIC HORMONE-REFRACTORY PROSTATE-CANCER
    HUDES, GR
    NATHAN, FE
    KHATER, C
    GREENBERG, R
    GOMELLA, L
    STERN, C
    MCALEER, C
    SEMINARS IN ONCOLOGY, 1995, 22 (05) : 41 - 45
  • [9] PROSTATE-CANCER - PLASMA-CONCENTRATIONS OF ESTRAMUSTINE PHOSPHATE AND ITS METABOLITES
    KIRDANI, RY
    KARR, JP
    MURPHY, GP
    SANDBERG, AA
    NEW YORK STATE JOURNAL OF MEDICINE, 1980, 80 (09) : 1390 - 1393
  • [10] ESTRAMUSTINE AFFECTS BONE-MINERAL METABOLISM IN METASTATIC PROSTATE-CANCER
    CITRIN, DL
    WALLEMARK, CB
    NADLER, R
    GEIGER, C
    TUTTLE, K
    KAPLAN, EH
    HAUCK, W
    CANCER, 1986, 58 (10) : 2208 - 2213
12345